DEFENDER Trademark

Trademark Overview

On Tuesday, June 28, 2022, a trademark application was filed for DEFENDER with the United States Patent and Trademark Office. The USPTO has given the DEFENDER trademark a serial number of 97479198. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, July 9, 2024. This trademark is owned by Currax Pharmaceuticals LLC. The DEFENDER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials in the field of smoking cessation for others
defender

General Information

Serial Number97479198
Word MarkDEFENDER
Filing DateTuesday, June 28, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 11, 2023

Trademark Statements

Goods and ServicesMedical and scientific research, namely, conducting clinical trials in the field of smoking cessation for others

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 16, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCurrax Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBrentwood, TN 37027
Party NameCurrax Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBrentwood, TN 37027

Trademark Events

Event DateEvent Description
Friday, July 1, 2022NEW APPLICATION ENTERED
Saturday, July 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 12, 2023ASSIGNED TO EXAMINER
Tuesday, April 18, 2023NON-FINAL ACTION WRITTEN
Tuesday, April 18, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, June 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 21, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2024SOU EXTENSION 1 FILED
Tuesday, September 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 9, 2024SOU EXTENSION 2 GRANTED
Tuesday, July 9, 2024SOU EXTENSION 2 FILED

Related Keywords

defender field smoking cessation others trials clinical scientific research namely conducting